by irenesoler | Mar 12, 2023 | Uncategorized
Baricitinib is the first JAK inhibitor approved in the US and Europe for the treatment of severe alopecia areata. In the UK the national institute for health and care excellence NICE evaluates new “technologies” for their efficacy and cost effectiveness...
by irenesoler | Dec 31, 2022 | Featured
It has taken an entire year to get a new Platelet Rich Plasma (PRP) service set up. Part of that is dealing with all the clinical governance and safety requirements that a private hospital expects, part of it is the procurement of equipment and then lastly the staff...
by irenesoler | Dec 12, 2021 | Uncategorized
Research into JAK inhibitors as a treatment for alopecia areata continues and we have now seen the first peer reviewed publication of a placebo controlled trial for the drug Baricitinib, showing response rates of over 50% achieving an improvement to less than 20%...
by irenesoler | Mar 28, 2021 | Uncategorized
So far, 2021 has been really busy in the private sector for dermatology. There is no doubt this is in part due to Covid, with difficulty for patients getting to see their own doctor and longer than normal waits in the NHS. Locally in the NHS, the average wait for a...
by irenesoler | Jan 24, 2021 | Uncategorized
The past year has seen a shift in how patients access healthcare. With limited access to GPs and challenges in getting seen and referred to NHS specialist care, more patients are choosing to take matters into their own hands and self refer for private healthcare. But...
